Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Iovance Biotherapeutics, Inc.
About IOVA
Iovance Biotherapeutics, Inc. is a commercial biotechnology company. The Company is focused on developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. Its products include Amtagvi and Proleukin. Amtagvi is indicated for the treatment of adult patients with melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor, with or without a MEK inhibitor. It is marketing Proleukin (aldesleukin), an interleukin-2 (IL-2) product used in the Amtagvi treatment regimen and in other applications. Amtagvi and Proleukin are part of a treatment regimen that includes lymphodepletion. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings and indications for solid tumor cancers. Its TIL therapy includes melanoma, non-small cell lung cancer and gynecologic cancer.
Find out what a historical investment in Iovance Biotherapeutics, Inc. would be worth today using our IOVA stock calculator.
Market Capitalisation
$1.54B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
8.92M
High today
$3.65
Low today
$3.48
Open price
$3.48
52-week high
$5.63
52-week low
$1.66
Ready to start your investing journey with Stake?
Open an accountHow do I buy IOVA shares in Australia?
Buying IOVA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Iovance Biotherapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IOVA
What is the ticker symbol of Iovance Biotherapeutics, Inc.?
The ticker symbol for Iovance Biotherapeutics, Inc. is IOVA.
How much is one share of IOVA?
One share of IOVA is valued at $3.55 as of 20 May 2026.
What is the market capitalisation of Iovance Biotherapeutics, Inc. IOVA?
As of 20 May 2026 Iovance Biotherapeutics, Inc. has a market cap of $1.54B.
What is the 52-week high for Iovance Biotherapeutics, Inc. stock?
The Iovance Biotherapeutics, Inc. 52-week high stock price is $5.63.
What is the 52-week low for Iovance Biotherapeutics, Inc. stock?
The Iovance Biotherapeutics, Inc. 52-week low stock price is $1.66.
Can I buy IOVA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IOVA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IOVA on Stake
- Buy IOVA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of IOVA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
IOVA related stocks